Fluzone is an inactivated Influenza virus vaccine indicated for active immunization against Influenza disease caused by Influenza virus subtypes A and B contained in the vaccine. It is prepared from Influenza viruses propagated in embryonated chicken eggs. It is licensed for use in persons 6 months of age and older.
- Children 6 through 35 months of age not previously vaccinated with an influenza vaccine, should receive two doses of 0.25 mL each at minimum interval of 4 weeks. Previously vaccinated children in this age group need to be given only one 0.25 mL dose
- Children 36 months through 8 years of age not previously vaccinated with an influenza vaccine, should receive two 0.5 mL doses at minimum interval of 1 month. Previously vaccinated children in this age group should receive only one 0.5 mL dose
- Children 9 years of age and older should receive a single 0.5 mL dose
Annual vaccination with the current vaccine is recommended because immunity during the year after vaccination declines, and also circulating strains of influenza virus change from year to year.
For latest IAP updates see revised immunization schedule.
Influenza vaccine (seasonal); split virion; inactivated
Do not administer Fluzone vaccine to anyone with a known severe hypersensitivity to egg proteins or any component of the vaccine or life-threatening reactions after previous administration of any influenza vaccine.